He Jin-Man, Shiao Yi-Tzone, Wang Yu-Chen, Chang Kuan-Cheng
Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Center of Institutional Research and Development, Asia University, Taichung, Taiwan.
J Formos Med Assoc. 2025 Jan 7. doi: 10.1016/j.jfma.2024.12.039.
Shortened door-to-balloon time (D2B) has been documented to confer cardiovascular benefits for ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PPCI). However, prolonged myocardial ischemic duration usually negates the beneficial effects due to delayed symptom-to-door time (S2D). In this study, we sought to investigate the joint effect of S2D-D2B in predicting clinical outcomes.
This study retrospectively enrolled 342 consecutive STEMI patients receiving PPCI. The baseline demographic data, clinical features, S2D, D2B, and S2B were compared between survivors and non-survivors. We further analyzed the relationships between mortality rates and S2D/D2B in patients with different age categories.
The receiver-operating characteristic curves analysis revealed D2B time 65. Mins, S2D time 125 min, and S2B time 170 min had the greatest predictive power for mortality rate. Patients with D2B < 65min and S2D time <125 min had the lowest mortality rate (1.62%). Whereas, patients with a D2B ≥ 65 min and S2D ≥ 125 min had the highest mortality rate (21%, P = 0.0004). Multiple variate analyses showed that combined D2B ≥ 65 min and S2D ≥ 125 min was an independent predictor for a higher mortality rate (HR 9.44, P = 0.0111). Shorter S2B time was also associated with a lower mortality rate in overall and younger populations.
The reductions of both D2B and S2D were associated with improved mortality rates in STEMI patients receiving PPCI, especially in younger populations. The findings call for community and healthcare system efforts to address these critical time intervals to enhance survival rates in STEMI patients.
缩短球囊扩张时间(D2B)已被证明可为接受直接经皮冠状动脉介入治疗(PPCI)的ST段抬高型心肌梗死(STEMI)患者带来心血管益处。然而,由于症状发作至入院时间(S2D)延长,心肌缺血持续时间延长通常会抵消这些有益效果。在本研究中,我们试图探讨S2D-D2B联合作用对预测临床结局的影响。
本研究回顾性纳入了342例连续接受PPCI的STEMI患者。比较了幸存者和非幸存者的基线人口统计学数据、临床特征、S2D、D2B和症状发作至球囊扩张时间(S2B)。我们进一步分析了不同年龄组患者死亡率与S2D/D2B之间的关系。
受试者工作特征曲线分析显示,D2B时间65分钟、S2D时间125分钟和S2B时间170分钟对死亡率具有最大预测能力。D2B<65分钟且S2D时间<125分钟的患者死亡率最低(1.62%)。而D2B≥65分钟且S2D≥125分钟的患者死亡率最高(21%,P = 0.0004)。多变量分析显示,D2B≥65分钟且S2D≥125分钟联合是较高死亡率的独立预测因素(风险比9.44,P = 0.0111)。较短的S2B时间在总体人群和年轻人群中也与较低的死亡率相关。
在接受PPCI的STEMI患者中,D2B和S2D的缩短均与死亡率改善相关,尤其是在年轻人群中。这些发现呼吁社区和医疗保健系统努力解决这些关键时间间隔,以提高STEMI患者的生存率。